NM_012193.4:c.1513C>T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_012193.4(FZD4):c.1513C>T(p.Gln505*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_012193.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FZD4 | NM_012193.4 | c.1513C>T | p.Gln505* | stop_gained | Exon 2 of 2 | ENST00000531380.2 | NP_036325.2 | |
| PRSS23 | NR_120591.3 | n.606G>A | non_coding_transcript_exon_variant | Exon 5 of 5 | ||||
| PRSS23 | NR_120592.2 | n.355G>A | non_coding_transcript_exon_variant | Exon 3 of 3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 449482). This premature translational stop signal has been observed in individuals with familial exudative vitreoretinopathy (PMID: 15223780, 23077402). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln505*) in the FZD4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 33 amino acid(s) of the FZD4 protein. -
The Q505X nonsense variant in the FZD4 gene has been reported previously in association with familial exudative vitreoretinopathy (FEVR) (Toomes et al., 2004). This variant is predicted to cause loss of normal protein function through protein truncation, as the final 33 amino acids are lost. The variant is not observed in large population cohorts (Lek et al., 2016). In summary, we consider this variant to be likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at